Korro Bio Inc KRRO

$9.64 -0.07 (-0.72%)

Valuation

Market cap
142,989,000
Revenue TTM
$6,390,000
Net income TTM
$-117,260,000
PE ratio
0.00
Forward PE
—
Profit margin
-1,835.05%
Debt to equity
0.00

Trading

Volume
153,100
Avg volume
141,618
Day's range
$9.48 – $9.90
Shares out
14,726,000
Stochastic %K
30%
Beta
3.14
Analysts
Strong Sell
Price target
$20.00

Price

Company profile

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA ed...

Show more

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 468 1999
Website
https://www.korrobio.com
Address
60 First Street, 2nd Floor Suite 250, Cambridge, United States

Latest news

Stocktwits

svallab1 Sep 21, 11:13 PM
$KRRO looks like this board is dead? Not even a single message since 3 day decline? Can anyone ahed some light into what may have caused this drop? I thought 11.11 was the bottom
1 replies
Arcides Sep 17, 7:55 PM
$KRRO
0 replies
jazzv Sep 17, 6:30 PM
$KRRO wut happened? why the drop?
0 replies
StockConsultant Sep 14, 4:27 PM
$KRRO Korro Bio stock, strong day, watch for a range breakout at https://www.stockconsultant.com/?KRRO Breakout trade WATCH for possible breakout above 15.24 Target: 21.22, 41.3% Stop: 12.96 Loss: 13.7% P/L ratio: 3 : 1 - Good BULLISH [Timing] Strong bullish 3 day candlestick pattern with Strong 3 day accumulation. [Timing] Extreme bullish 1 day moneyflow [Timing] Breakout trade watch above 15.24, no resistance in area just above. BEARISH [Positioning] at resistance
0 replies
PhishTourFunds Sep 8, 8:29 PM
$KRRO There was a 1:50 r/s in 2023 that corrected the float ~ that gnarly wick down would be the exit liquidity ~ now the slow grind up with little sustained volume 👁️👁️ And now we have institutional hammer of inflow!
1 replies
johnnygogogo Sep 8, 3:29 PM
$WVE $PRQR $KRRO if the underwriters / MMs want to successfully sell an ADARx ipo, they’re going to have to lift the valuations of these three, otherwise investors won’t buy what they’re selling at the valuation they want and instead buy the discount on the already established and already public
0 replies
Estimize Aug 20, 10:01 AM
Wall St is expecting -1.26 EPS for $KRRO Q3 [Reporting 11/18 BMO] http://www.estimize.com/intro/krro?chart=historical&metric_name=eps&utm_c
0 replies
CamilaCruze Aug 9, 7:46 PM
$KRRO Strong cash position: $137.9M cash/securities at June 30, with runway into H2 2028💰
0 replies